Combining neurologic and blood pressure drugs reduce breast tumor development in mice

According to a new study combining drugs used to treat bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high-fat diet fed to their mothers during pregnancy. Valproic acid was the main drug in the study protocol, which inhibits histone deacetylase (HDAC), an essential gene epigenetic silencer. The research finding indicates how impactful the addition or subtraction from DNA of an epigenetic methyl group can be along with the diet which plays a major role in cancer risk patients.

Reference link: https://medicalxpress.com/news/2019-12-combining-neurologic-blood-pressure-drugs.html

Tough breast cancer can be treated using an anti-evolution drug

New generation remedies for cancer treatments are challenging resilient cancer conditions in patients. Previously known as BOS172722, was tested in animals to study the effectiveness of paclitaxel which is kind of Chemotherapy used in treating triple-negative breast cancer, one of deadliest breast cancer known to mankind.

A human trial of this procedure is scheduled to be performed. If it is a success, it can be expanded to treat lung and ovarian cancer.

Reference Link: https://www.newscientist.com/article/2218935-anti-evolution-drug-may-help-treat-resistant-breast-cancers/